Immunogenicity and Safety of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu) in Adults and Elderly in Korea.
Phase of Trial: Phase IV
Latest Information Update: 10 Jan 2014
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 14 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Oct 2010 New trial record